<DOC>
	<DOCNO>NCT00898742</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study look gene protein expression pattern predict response cetuximab patient recurrent and/or metastatic head neck cancer .</brief_summary>
	<brief_title>Gene Protein Expression Patterns Predicting Response Cetuximab Patients With Recurrent and/or Metastatic Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To identify 100 patient Head Neck Tumor Tissue Repository Clinical Database treat cetuximab monotherapy cetuximab-containing combination therapy standard care recurrent and/or metastatic head neck squamous cell carcinoma Vanderbilt University Medical Center . - To assay diversity gene protein expression pattern see patient . - To identify predictive pattern associate treatment response survival patient correlate laboratory data clinical data . OUTLINE : Tumor tissue specimens clinical data obtain Head Neck Tumor Tissue Repository Clinical Database protocol VU-VICC-HN-0356 . Specimens analyze pattern gene protein expression predictive cetuximab treatment response survival DNA microarray , tissue microarray , reverse transcriptase-PCR , mass spectroscopy .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis recurrent and/or metastatic head neck squamous cell carcinoma Enrolled Head Neck Tissue Repository Clinical Database protocol VUVICCHN0356 Previously treat cetuximab monotherapy cetuximabbased combination therapy Sufficient biological material available analysis PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>